Hong Kong Med J 2011;17(Suppl 3):S20-4
Cervical cancer prevention through cytologic and human papillomavirus DNA screening in Hong Kong Chinese women
J Wu
School of Public Health, The University of Hong Kong, Hong Kong
1. Since the launch of the cervical screening programme, the ever-screened rate has increased significantly from 37% in 2003 to 64% in 2008.
2. Using Hong Kong specific data on age-specific human papillomavirus (HPV) prevalence and cervical cancer incidence, the first cost-effectiveness analysis of the role of adjunctive HPV DNA testing was conducted.
3. Based on the principle that revision to current practice should not reduce effectiveness, the cost-effectiveness analysis suggests that 1,1,3-yearly cytology screening with HPV DNA testing is an optimal testing paradigm.